{"id":78342,"date":"2024-07-24T21:33:23","date_gmt":"2024-07-24T19:33:23","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=78342"},"modified":"2026-04-08T10:50:45","modified_gmt":"2026-04-08T08:50:45","slug":"veeva-pulse-field-trends-report-2q24","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-pulse-field-trends-report-2q24\/","title":{"rendered":"³Ô¹Ï±¬ÁÏ Pulse Field Trends Report"},"content":{"rendered":"<br \/>\n<style>\n  p.font-22, li.font-22 {\n  font-size:22px !important;\n  line-height:30px !important;\n  }\n@media screen and (max-width: 767px){\n p.font-22, li.font-22  {\n  font-size:19px !important;\n  line-height:26px !important;\n  }\n}<\/p>\n<p>    p.font-14 {\n  font-size:14px;\n  line-height:20px;\n  }<\/p>\n<p>  .after-arrow-down-orange, .after-arrow-up-orange {\n    color: #F7981D;\n}\n  .after-arrow-down-orange::after {\n    display: inline-block;\n    content: \"\";\n    font-size: 0;\n    margin-left: 5px;\n    margin-bottom: 1px;\n    width: 0;\n    height: 0;\n    border-style: solid;\n    border-width: 7px 5px 0 5px;\n    border-color: #F7981D transparent transparent transparent;\n}\n.after-arrow-up-orange::after {\n    display: inline-block;\n    content: \"\";\n    font-size: 0;\n    margin-left: 5px;\n    margin-bottom: 1px;\n    width: 0;\n    height: 0;\n    border-style: solid;\n    border-width: 0px 5px 7px 5px;\n    border-color:  transparent transparent #F7981D transparent;\n}\n.after-arrow-down-orange:hover::after {\n    border-color: #e97f16 transparent transparent transparent;\n}\n.after-arrow-up-orange:hover::after {\n    border-color: transparent transparent  #e97f16 transparent;\n}<\/p>\n<p>.after-arrow-down-orange.active,.after-arrow-up-orange.active {\n    color: #FA6D18;\n}\n.after-arrow-down-orange.active::after {\n    border-color: #FA6D18 transparent transparent transparent;\n}\n.after-arrow-up-orange.active::after {\n    border-color: transparent transparent #FA6D18  transparent;\n}<\/p>\n<p>.down-links  {\npadding:12px 0;\ntext-align:center;\nmargin-top:60px;\nmargin-bottom:40px;\ndisplay:none!important;\n}\n.down-links a {\nfont-size:15px; line-height:21px;\n}\n.down-links div {\ndisplay:inline-block;\npadding:5px 16px;\nwhite-space:nowrap;\n}\n.generic-container h3 {\nfont-weight:500;\nmargin-top:35px;\nmargin-bottom:20px;\n}\np.pulse-sub {\nfont-size:26px;\nline-height:33px;\n}\np.pulse-sub span {\ndisplay:block;\nfont-weight:500;\n}\n.resources-content hr {\nmargin-top: 50px;\nmargin-bottom: 10px;\nborder: 0;\nborder-top: 2px solid #afafaf;\n}\n.resources-content hr.divide {\nmargin-top: 50px;\nmargin-bottom: 40px;\nborder: 0;\nborder-top: 1px solid #ccc;\n}\n.resources-content h2 {\nmargin-bottom:30px;\nfont-weight:500;\nfont-size:30px;\n}\n.resources-content h2.fake-h1 {\nmargin-bottom:30px;\nfont-weight:300;\nfont-size: 38px;\n}\n@media (max-width: 767px) {\n    .resources-content h2.fake-h1 {\nmargin-bottom:25px;\nfont-weight:300;\nfont-size: 30px;\n}\n.resources-content h2 {\nmargin-bottom:25px;\nfont-weight:400;\nfont-size:25px;\n}\np.pulse-sub {\nfont-size:22px;\nline-height:30px;\n}\n.down-links  {\npadding:12px 0;\ntext-align:center;\nmargin-top:40px;\nmargin-bottom:40px;\n}\n}\n@media (max-width: 450px) {\n.down-links div {\ndisplay:block;\npadding:5px 20px;\nwhite-space:nowrap;\n}\n}<\/p>\n<p>@media only screen and (min-width: 768px) and (max-width: 960px) {\n    .down-links div {\n        padding: 5px 10px;\n    }\n    .down-links a {\n        font-size: 12px;\n    }\n}<\/p>\n<p>@media only screen and (min-width: 961px) and (max-width: 996px) {\n    .down-links div {\n        padding: 5px 14px;\n    }\n    .down-links a {\n        font-size: 14px;\n    }\n}\n.insight-box {\ndisplay:flex;\n}\n@media (max-width: 767px) {\n.insight-box {\ndisplay:block !important;\n}\n}\n.insights-sub {\nfont-size:26px;line-height:32px;font-weight:500;margin-bottom:5px;\n}\n@media (max-width: 767px) {\n.insights-sub {\nfont-size:22px;line-height:28px;font-weight:500;margin-bottom:5px;\n}\n}<\/p>\n<p>.insights-grey-box {\nbackground:#444;color:white;padding:30px 50px 30px 20px;height:100%\n}\n<\/style>\n<h2 class=\"mt-40 mb-10\">Treatment Adoption is 40% Faster with Targeted Scientific Outreach<\/h2>\n<h3 class=\"mt-0\">Engaging digitally savvy, early-career HCPs amplifies impact<\/h3>\n<p>\nChallenging disease states, innovative new medicines, and increasingly complex clinical trials have raised the stakes for<br \/>\nnew product launches. Breaking through to healthcare professionals (HCP) with new scientific evidence is a core<br \/>\nchallenge, as they contend with huge volumes of information across disparate channels. How biopharmas<br \/>\ncommunicate scientific evidence is key to maximizing launch success.\n<\/p>\n<p>\nPulse data has shown that pre-launch field medical education <a href=\"\/eu\/resources\/veeva-pulse-field-trends-report-1q2q23\/\">improves treatment adoption by 50%<\/a>. Now, our latest<br \/>\nanalysis shows that pre-launch investment in scientific outreach beyond field medical, in forums like congresses, has a<br \/>\nmaterial impact. In an analysis of U.S. oncology drugs, higher levels of pre-launch scientific activity accelerated<br \/>\ntreatment adoption by 40%. These findings underscore the quantifiable impact that targeted medical affairs strategies<br \/>\nhave on launch success.\n<\/p>\n<p>\nRead our analysis to learn how pre-launch investment in scientific outreach sets the stage for faster treatment adoption<br \/>\nand, ultimately, commercial success at launch and beyond.\n<\/p>\n<p>Thank you,<\/p>\n<p><img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/11\/signature.png\" alt=\"\"><\/p>\n<p>\nDan Rizzo<br \/>\nGlobal Head of ³Ô¹Ï±¬ÁÏ Business Consulting\n<\/p>\n<p><img decoding=\"async\" style=\"border-radius:50%\"  src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2022\/04\/Headshot-Rizzo.png\" alt=\"\"><\/p>\n<hr class=\"divide\">\n<h2 class=\"mt-40 mb-20\">Pre-launch scientific outreach accelerates treatment adoption by 40%<\/h2>\n<p class=\"font-22\">\nIn a study of oncology drugs in the U.S., biopharmas that invested more in pre-launch scientific<br \/>\nactivities, e.g., congresses, clinical trials, and publications, saw 40% faster treatment adoption than<br \/>\nbiopharmas that invested less. A robust pre-launch scientific communications strategy optimizes<br \/>\nlaunch success by meeting HCPs and other experts where they are, on their terms.\n<\/p>\n<p class=\"font-22\">\nPre-launch field medical education <a href=\"\/eu\/resources\/veeva-pulse-field-trends-report-1q2q23\/\">improves treatment adoption by 50%<\/a>. By connecting medical<br \/>\naffairs HQ and field medical activity and <a href=\"\/eu\/medicalimpact\/\">measuring impact<\/a> during this critical window,<br \/>\nbiopharmas can create the best opportunity to influence treatment adoption.<\/p>\n<h3>Defining scientific activity:<br \/>\n<span style=\"font-weight:300\"><br \/>\nNon-promotional medical or scientific initiatives, including congresses, social media activity, publications,<br \/>\nguidelines, and clinical trials<span><br \/>\n<\/h3>\n<h3 class=\"text-center\">Impact of Pre-Launch Scientific Outreach<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-1.png\" alt=\"\" \/><\/p>\n<h2 class=\"mt-40 mb-20\">Congress activity has the strongest influence on speed of adoption<\/h2>\n<p class=\"font-22\">\nNot all channels of scientific activity are created equal \u2014 how biopharmas reach experts can have<br \/>\na measurable impact on success. Across the oncology drugs studied, higher investment in<br \/>\ncongress activities pre-launch most strongly influenced speed to treatment adoption post-approval.\n<\/p>\n<p class=\"font-22\">\nWhile clinical trials and publications are important foundational elements of scientific<br \/>\ncommunication, the analysis found a much lower correlation between these activities and<br \/>\ntreatment adoption. Congresses and the digital discussions kicked off by those events (e.g.,<br \/>\ndiscussions on social media) create a halo effect that amplifies scientific information. <a href=\"\/eu\/products\/veeva-link\/overview\/\">Deep data<\/a><br \/>\non KOLs and other experts can help medical affairs understand which congresses present the<br \/>\nbest opportunity to drive scientific engagement.\n<\/p>\n<h3 class=\"text-center\">Not All Channels Are Created Equal<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-2-1.png\" alt=\"\" \/><\/p>\n<h2 class=\"mt-50 mb-20\">Digitally savvy, early-career HCPs are four times more likely to adopt<br \/>\na new treatment<\/h2>\n<p class=\"font-22\">\nThere is significant untapped potential in early-career HCPs, who are 15 years younger, digitally<br \/>\nsavvy, and more scientifically active than their peers. The analysis found that these emerging<br \/>\nexperts are four times more likely to adopt a new treatment.\n<\/p>\n<p class=\"font-22 mb-10\" style=\"color:#F46700\">\n<strong>\u201cGone are the days when medical could just focus on the top-tier scientific thought leaders.<br \/>\nThe range of stakeholders has broadened, and it\u2019s imperative to expand our engagement<br \/>\nstrategies beyond traditional experts.\u201d<\/strong>\n<\/p>\n<p>\nAngela Smart, Director of Global Medical Excellence and Operations at ADVANZ PHARMA\n<\/p>\n<p class=\"font-22\">\nDeep data on activities like congresses, social media posts, and publications can help identify,<br \/>\nprioritize, and engage these experts. Understanding this demographic\u2019s digital and scientific<br \/>\nbehaviors, in addition to investing in the right scientific channels, can maximize treatment<br \/>\nadoption.\n<\/p>\n<h3 class=\"text-center\">Untapped Potential of Digitally Savvy, Early-Career HCPs<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-3.png\" alt=\"\" \/><\/p>\n<p  class=\"font-22 mt-30\">\nBiopharmas have an opportunity to maximize launch success by:\n<\/p>\n<ul>\n<li class=\"font-22\">Coordinating the efforts of medical affairs and field medical, including sharing medical insights that improve commercial and clinical decision-making<\/li>\n<li class=\"font-22\">Benchmarking investments in scientific outreach, ensuring appropriate resources to support launch strategy, and measuring the ROI of outreach for each disease area<\/li>\n<li class=\"font-22\">Using deep data to identify, prioritize, and engage experts with targeted scientific outreach<\/li>\n<\/ul>\n<p class=\"mt-50\">\n<strong>Reach out to <a href=\"\/eu\/services\/business-consulting-services\/\">³Ô¹Ï±¬ÁÏ Business Consulting<\/a> to learn how you can use ³Ô¹Ï±¬ÁÏ Pulse data to achieve data-driven launch<br \/>\nexcellence. <\/strong>\n<\/p>\n<hr class=\"divide\">\n<h2 style=\"text-align:center\" class=\"fake-h1\">Global and Regional Trends<\/h2>\n<p>This report highlights global and regional field engagement trends from ³Ô¹Ï±¬ÁÏ Pulse data gathered between April 2023<br \/>\nand June 2024. ³Ô¹Ï±¬ÁÏ Pulse data is sourced from ³Ô¹Ï±¬ÁÏ\u2019s aggregated CRM activity, including field engagement stats<br \/>\nfrom all instances of ³Ô¹Ï±¬ÁÏ CRM globally. <strong>In this report, all comparisons are year-over-year, Q2 2023 to Q2 2024,<br \/>\nunless otherwise noted.<\/strong><\/p>\n<div class=\"row down-links mt-40\" style=\"background-color:#f4f4f4\">\n<div>\n\t\t<a href=\"#Global\" class=\"after-arrow-down-orange quicklink active\">Global trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#US\" class=\"after-arrow-down-orange quicklink\">U.S. trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Europe\" class=\"after-arrow-down-orange quicklink\">Europe trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Asia\" class=\"after-arrow-down-orange quicklink\">Asia trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Latam\" class=\"after-arrow-down-orange quicklink\">Latin America trends<\/a>\n\t<\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"Global\" style=\"position: absolute;top: -200px;\"><\/a>\n<\/div>\n<h2>Global trends*<\/h2>\n<h3 class=\"text-center\">Figure 1: Channel mix evolution, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-1-Channel-Mix-Evolution-Global.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 2: Channel mix, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-2-Channel-Mix-Global.png\" alt=\"\" \/><\/p>\n<hr>\n<p class=\"pulse-sub\">\n<span>Global field team activity<\/span><br \/>\nWeekly activity per user by engagement channel\n<\/p>\n<h3 class=\"text-center\">Figure 3: Activity by region, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-3-Activity-by-Region-Global.png\" alt=\"\" \/><\/p>\n<div class=\"row\">\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 4: Activity by user type, global<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-4-Activity-by-User-Type-Global.png\" alt=\"\" \/>\n\t<\/div>\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 5: Activity by company size, global<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-5-Activity-by-Company-Size-Global.png\" alt=\"\" \/>\n\t<\/div>\n<\/div>\n<hr>\n<p class=\"pulse-sub\">\n<span>Global engagement quality<\/span><br \/>\nConsolidation of key quality metrics\n<\/p>\n<h3 class=\"text-center\">Figure 6: Approved email volume, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-6-Approved-Email-Volume-Global.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 7: Content usage by channel, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-7-Content-Usage-by-Channel-Global.png?v=1.0\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 8: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, global<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-8-Meeting-Duration-Global.png\" alt=\"\" \/><\/p>\n<p class=\"font-14\" style=\"margin-top:20px\">\n<em>*This quarter\u2019s global trends report omits data from China.<\/em>\n<\/p>\n<div class=\"row down-links mt-40\" style=\"background-color:#f4f4f4\">\n<div>\n\t\t<a href=\"#Global\" class=\"after-arrow-up-orange quicklink\">Global trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#US\" class=\"after-arrow-down-orange quicklink  active\">U.S. trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Europe\" class=\"after-arrow-down-orange quicklink\">Europe trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Asia\" class=\"after-arrow-down-orange quicklink\">Asia trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Latam\" class=\"after-arrow-down-orange quicklink\">Latin America trends<\/a>\n\t<\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"US\" style=\"position: absolute;top: -200px;\"><\/a>\n<\/div>\n<h2>U.S. market trends<\/h2>\n<h3 class=\"text-center\">Figure 9: Channel mix evolution, U.S.<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-9-Channel-Mix-Evolution-US.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 10: Channel mix, U.S.<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-10-Channel-Mix-US.png\" alt=\"\" \/><\/p>\n<hr>\n<p class=\"pulse-sub\">\n<span>U.S. field team activity<\/span><br \/>\nWeekly activity per user by engagement channel\n<\/p>\n<h3 class=\"text-center\">Figure 11: Activity, U.S.<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-11-Activity-US.png\" alt=\"\" \/><\/p>\n<div class=\"row\">\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 12: Activity by user type, U.S.<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-12-Activity-by-User-Type-US.png\" alt=\"\" \/>\n\t<\/div>\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 13: Activity by company size, U.S.<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-13-Activity-by-Company-Size-US.png\" alt=\"\" \/>\n\t<\/div>\n<\/div>\n<hr>\n<p class=\"pulse-sub\">\n<span>U.S. engagement quality<\/span><br \/>\nConsolidation of key quality metrics\n<\/p>\n<h3 class=\"text-center\">Figure 14: Approved email volume, U.S.<\/h4>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-14-Approved-Email-Volume-US-2.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 15: Content usage by channel, U.S.<\/h4>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-15-Content-Usage-by-Channel-US.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 16: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, U.S.<\/h4>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-16-Meeting-Duration-US.png\" alt=\"\" \/><\/p>\n<div class=\"row down-links mt-40\" style=\"background-color:#f4f4f4\">\n<div>\n\t\t<a href=\"#Global\" class=\"after-arrow-up-orange quicklink\">Global trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#US\" class=\"after-arrow-up-orange quicklink\">U.S. trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Europe\" class=\"after-arrow-down-orange quicklink active\">Europe trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Asia\" class=\"after-arrow-down-orange quicklink\">Asia trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Latam\" class=\"after-arrow-down-orange quicklink\">Latin America trends<\/a>\n\t<\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"Europe\" style=\"position: absolute;top: -200px;\"><\/a>\n<\/div>\n<h2>Europe market trends <\/h2>\n<h3 class=\"text-center\">Figure 17: Channel mix evolution, Europe<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-17-Channel-Mix-Evolution-Europe.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 18: Channel mix, Europe<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-18-Channel-Mix-Europe.png\" alt=\"\" \/><\/p>\n<hr>\n<p class=\"pulse-sub\">\n<span>Europe field team activity<\/span><br \/>\nWeekly activity per user by engagement channel\n<\/p>\n<h3 class=\"text-center\">Figure 19: Activity by country, EU5<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-19-Activity-by-Region-EU5.png\" alt=\"\" \/><\/p>\n<div class=\"row\">\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 20: Activity by user type, Europe<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-20-Activity-by-User-Type-Europe.png\" alt=\"\" \/>\n\t<\/div>\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 21: Activity by company size, Europe<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-21-Activity-by-Company-Size-Europe.png\" alt=\"\" \/>\n\t<\/div>\n<\/div>\n<hr>\n<p class=\"pulse-sub\">\n<span>Europe engagement quality<\/span><br \/>\nConsolidation of key quality metrics\n<\/p>\n<h3 class=\"text-center\">Figure 22: Approved email volume, Europe<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-22-Approved-Email-Volume-Europe.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 23: Content usage by channel, Europe<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-23-Content-Usage-by-Channel-Europe.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 24: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Europe<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-24-Meeting-Duration-Europe.png\" alt=\"\" \/><\/p>\n<div class=\"row down-links mt-40\" style=\"background-color:#f4f4f4\">\n<div>\n\t\t<a href=\"#Global\" class=\"after-arrow-up-orange quicklink\">Global trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#US\" class=\"after-arrow-up-orange quicklink\">U.S. trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Europe\" class=\"after-arrow-up-orange quicklink\">Europe trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Asia\" class=\"after-arrow-down-orange quicklink active\">Asia trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Latam\" class=\"after-arrow-down-orange quicklink\">Latin America trends<\/a>\n\t<\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"Asia\" style=\"position: absolute;top: -200px;\"><\/a>\n<\/div>\n<h2>Asia market trends<\/h2>\n<h3 class=\"text-center\">Figure 25: Channel mix evolution, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-25-Channel-Mix-Evolution-APAC.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 26: Channel mix, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-26-Channel-Mix-APAC.png\" alt=\"\" \/><\/p>\n<hr>\n<p class=\"pulse-sub\">\n<span>Asia field team activity<\/span><br \/>\nWeekly activity per user by engagement channel\n<\/p>\n<h3 class=\"text-center\">Figure 27: Activity by country, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-27-Activity-by-Region-APAC.png\" alt=\"\" \/><\/p>\n<div class=\"row\">\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 28: Activity by user type, Asia<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-28-Activity-by-User-Type-APAC.png\" alt=\"\" \/>\n\t<\/div>\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 29: Activity by company size, Asia<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-29-Activity-by-Company-Size-APAC.png\" alt=\"\" \/>\n\t<\/div>\n<\/div>\n<hr>\n<p class=\"pulse-sub\">\n<span>Asia engagement quality<\/span><br \/>\nConsolidation of key quality metrics\n<\/p>\n<h3 class=\"text-center\">Figure 30: Approved email volume, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-30-Approved-Email-Volume-APAC.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 31: Content usage by channel, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-31-Content-Usage-by-Channel-APAC.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 32: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Asia<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-32-Meeting-Duration-APAC.png\" alt=\"\" \/><\/p>\n<div class=\"row down-links mt-40\" style=\"background-color:#f4f4f4\">\n<div>\n\t\t<a href=\"#Global\" class=\"after-arrow-up-orange quicklink\">Global trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#US\" class=\"after-arrow-up-orange quicklink\">U.S. trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Europe\" class=\"after-arrow-up-orange quicklink\">Europe trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Asia\" class=\"after-arrow-up-orange quicklink\">Asia trends<\/a>\n\t<\/div>\n<div>\n\t\t<a href=\"#Latam\" class=\"after-arrow-down-orange quicklink active\">Latin America trends<\/a>\n\t<\/div>\n<\/div>\n<div style=\"position:relative;\">\n  <a id=\"Latam\" style=\"position: absolute;top: -200px;\"><\/a>\n<\/div>\n<h2>Latin America market trends*<\/h2>\n<h3 class=\"text-center\">Figure 33: Channel mix evolution, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-33-Channel-Mix-Evolution-LATAM.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 34: Channel mix, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-34-Channel-Mix-LATAM.png\" alt=\"\" \/><\/p>\n<hr>\n<p class=\"pulse-sub\">\n<span>Latin America field team activity <\/span><br \/>\nWeekly activity per user by engagement channel\n<\/p>\n<h3 class=\"text-center\">Figure 35: Activity by country, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-35-Activity-by-Counry-LATAM.png\" alt=\"\" \/><\/p>\n<div class=\"row\">\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 36: Activity by user type, Latin America<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-36-Activity-by-User-Type-LATAM.png\" alt=\"\" \/>\n\t<\/div>\n<div class=\"col-sm-6\">\n<h3 class=\"text-center\">Figure 37: Activity by company size, Latin America<\/h3>\n<p>\t\t<img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-37-Activity-by-Company-Size-LATAM.png\" alt=\"\" \/>\n\t<\/div>\n<\/div>\n<hr>\n<p class=\"pulse-sub\">\n<span>Latin America engagement quality <\/span><br \/>\nConsolidation of key quality metrics\n<\/p>\n<h3 class=\"text-center\">Figure 38: Approved email volume, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-38-Approved-Email-Volume-LATAM.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 39: Content usage by channel, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-39-Content-Usage-by-Channel-LATAM.png\" alt=\"\" \/><\/p>\n<h3 class=\"text-center\">Figure 40: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Latin America<\/h3>\n<p><img decoding=\"async\" class=\"img-responsive m-auto\" src=\"\/wp-content\/uploads\/2024\/07\/Figure-40-Meeting-Duration-LATAM.png\" alt=\"\" \/><\/p>\n<p class=\"font-14\" style=\"margin-top:20px\">\n<em>*Multiple new LATAM pharma companies were added, increasing weekly activity volume. <\/em>\n<\/p>\n<hr class=\"mb-0\" style=\"border-top: 4px solid #444;\">\n<h2 class=\"fake-h1 mt-10\">Appendix: Data dictionary<\/h2>\n<p class=\"pulse-sub\">\n<span>Metric definitions<\/span>\n<\/p>\n<ul>\n<li><strong>Channel mix evolution over time:<\/strong> Weekly ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat, or text)<\/li>\n<li><strong>Channel mix:<\/strong> Total ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by engagement channel percentage<\/li>\n<li><strong>Weekly activities per user:<\/strong> The average weekly number of ³Ô¹Ï±¬ÁÏ CRM activities submitted per number of users active in ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>Approved email volume:<\/strong> Volume of approved emails sent via ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>Email open rate:<\/strong> Percentage of approved emails opened at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>Email click rate:<\/strong> Percentage of approved emails clicked at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>In-person % CLM usage:<\/strong> Percentage of in-person engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>Video % CLM usage:<\/strong> Percentage of video engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>³Ô¹Ï±¬ÁÏ CRM Engage meeting % CLM usage:<\/strong> Percentage of ³Ô¹Ï±¬ÁÏ CRM Engage meetings that leveraged content in ³Ô¹Ï±¬ÁÏ CRM<\/li>\n<li><strong>³Ô¹Ï±¬ÁÏ CRM Engage meeting duration:<\/strong> The average duration of ³Ô¹Ï±¬ÁÏ CRM Engage meetings in minutes<\/li>\n<\/ul>\n<p class=\"pulse-sub mt-30\">\n<span>Engagement channel definitions<\/span>\n<\/p>\n<ul>\n<li><strong>In-person:<\/strong> Submitted calls with a CRM Standard Metrics call channel value of \u2018in-person\u2019<\/li>\n<li><strong>Phone:<\/strong> Submitted calls with a CRM Standard Metrics call channel value of \u2018phone\u2019<\/li>\n<li><strong>Video:<\/strong> ³Ô¹Ï±¬ÁÏ CRM Engage calls and video calls via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of \u2018video\u2019<\/li>\n<li><strong>Email:<\/strong> Approved emails and emails sent via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of \u2018email\u2019<\/li>\n<li><strong>Chat or text:<\/strong> Submitted calls with a CRM Standard Metrics call channel value of \u2018chat or text\u2019<\/li>\n<\/ul>\n<p class=\"pulse-sub mt-30\">\n<span>User type definitions<\/span>\n<\/p>\n<ul>\n<li><strong>Sales:<\/strong> Users that have been classified with the \u2018sales\u2019 value in the CRM Standard Metrics user type field<\/li>\n<li><strong>Key account manager:<\/strong> Users that have been classified with the \u2018key account manager\u2019 value in the CRM Standard Metrics user type field<\/li>\n<li><strong>Medical:<\/strong> Users that have been classified with the \u2018medical\u2019 value in the CRM Standard Metrics user type field<\/li>\n<li><strong>Top global biopharma:<\/strong> Top 17 global biopharma companies by revenue<\/li>\n<li><strong>Rest of industry:<\/strong> All other biopharmas<\/li>\n<\/ul>\n<p class=\"pulse-sub mt-30\">\n<span>Region definitions<\/span>\n<\/p>\n<ul>\n<li><strong>Global:<\/strong> All markets globally. This quarter\u2019s global trends report omits data from China. <\/li>\n<li><strong>Europe:<\/strong> Albania, Andorra, Armenia, Aruba, Austria, Azerbaijan, Belarus, Belgium, Bermuda, Bosnia and Herzegovina,<br \/>\nBulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, French Polynesia, Georgia, Germany,<br \/>\nGreece, Greenland, Guadeloupe, Guernsey, Hungary, Ireland, Italy, Jersey, Latvia, Lithuania, Luxembourg, Macedonia,<br \/>\nMalta, Martinique, Republic of Moldova, Monaco, Montenegro, Netherlands, New Caledonia, Norway, Poland, Portugal,<br \/>\nRomania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom<\/li>\n<li><strong>Asia:<\/strong> Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, Cocos (Keeling) Islands, Indonesia, Japan,<br \/>\nKazakhstan, Republic of Korea, Kyrgyzstan, Malaysia, Mongolia, Myanmar, Nauru, Nepal, New Zealand, Philippines,<br \/>\nSamoa, Singapore, Solomon Islands, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, Vietnam<\/li>\n<li><strong>Latin America:<\/strong> Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Trinidad and Tobago, Uruguay, Venezuela. Multiple new LATAM pharma companies were added, increasing weekly activity volume.<\/li>\n<\/ul>\n<h2 class=\"fake-h1\">Methodology<\/h2>\n<p>\nThe <a href=\"\/eu\/resources\/veeva-hcp-360-trends-report\/\">³Ô¹Ï±¬ÁÏ HCP 360 Trends Report<\/a> is a quarterly industry benchmark for global and regional healthcare professional<br \/>\n(HCP) engagement across the life sciences industry. The report is based on approximately 600 million annual global<br \/>\nfield activities captured in <a href=\"\/eu\/products\/crm-suite\/\">³Ô¹Ï±¬ÁÏ CRM<\/a> and <a href=\"\/eu\/products\/crm-suite\/engage\/\">³Ô¹Ï±¬ÁÏ CRM Engage<\/a>, along with more than three million curated profiles from<br \/>\n<a href=\"\/eu\/products\/veeva-link\/\">³Ô¹Ï±¬ÁÏ Link Key People<\/a>  and global reference data of HCPs and HCOs in 65+ countries from <a href=\"\/eu\/products\/opendata\/\">³Ô¹Ï±¬ÁÏ OpenData<\/a>. In addition, this study utilized anonymous patient longitudinal claims data from <a href=\"https:\/\/www.veeva.com\/products\/veeva-compass\/patient\/\">³Ô¹Ï±¬ÁÏ Compass<br \/>\nPatient<\/a> covering dispensed prescriptions, procedures, and diagnoses from more than 300 million patients.\n<\/p>\n<p>\nThe ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report delivers insights that inform the industry and help field teams align their strategy to<br \/>\nkey market trends for improved commercial success. The global ³Ô¹Ï±¬ÁÏ Business Consulting team also helps customers<br \/>\ninform their strategies using industry benchmarking with ³Ô¹Ï±¬ÁÏ Pulse data.\n<\/p>\n<p class=\"font-14\">\n<em>*All trending chart insights (except Figure 7) are calculated using an average weekly percent change during the specified time period.<\/em>\n<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Treatment Adoption is 40% Faster with Targeted Scientific Outreach<\/p>\n","protected":false},"featured_media":78343,"parent":0,"template":"","class_list":["post-78342","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-commercial","resource-area-20-data","resource-area-20-medical","resource-product-20-approved-email","resource-product-20-campaign-manager","resource-product-20-clm","resource-product-20-commercial-content-promomats","resource-product-20-commercial-data-warehouse-nitro","resource-product-20-crm","resource-product-20-medical-crm","resource-product-20-deep-key-account-data-link","resource-product-20-real-time-customer-intelligence-link","resource-product-20-digital-engagement-engage","resource-product-20-events-management","resource-product-20-field-planning-alignments-align-territory-designer","resource-product-20-hcp-access-data","resource-product-20-key-account-management","resource-product-20-network-mdm","resource-product-20-reference-data-opendata-clinical","resource-product-20-customer-reference-data-opendata","resource-type-report"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/78342"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":0,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/78342\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/78343"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=78342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}